Article info

Download PDFPDF
Screening for postmenopausal osteoporosis with any modality is cost-effective including screening initiation at 55 years of age

Authors

  1. Correspondence to: Gavin Peter Ross Clunie
    Department of Rheumatology, The Ipswich Hospital, Heath Rd, Ipswich, Suffolk IP4 5PD, UK; gavin.clunie{at}doctors.org.uk
View Full Text

Citation

Clunie G
Screening for postmenopausal osteoporosis with any modality is cost-effective including screening initiation at 55 years of age

Publication history

  • First published July 10, 2012.
Online issue publication 
November 28, 2012

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.